Literature DB >> 26999313

Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis.

Julieta Marrone1, Leandro R Soria1, Mauro Danielli1, Guillermo L Lehmann1, Maria Cecilia Larocca1, Raúl A Marinelli1.   

Abstract

UNLABELLED: The adenoviral gene transfer of human aquaporin-1 (hAQP1) water channels to the liver of 17α-ethinylestradiol-induced cholestatic rats improves bile flow, in part by enhancing canalicular hAQP1-mediated osmotic water secretion. To gain insight into the mechanisms of 17α-ethinylestradiol cholestasis improvement, we studied the biliary output of bile salts (BS) and the functional expression of the canalicular BS export pump (BSEP; ABCB11). Adenovector encoding hAQP1 (AdhAQP1) or control vector was administered by retrograde intrabiliary infusion. AdhAQP1-transduced cholestatic rats increased the biliary output of major endogenous BS (50%-80%, P < 0.05) as well as that of taurocholate administered in choleretic or trace radiolabel amounts (around 60%, P < 0.05). Moreover, liver transduction with AdhAQP1 normalized serum BS levels, otherwise markedly elevated in cholestatic animals. AdhAQP1 treatment was unable to improve BSEP protein expression in cholestasis; however, its transport activity, assessed by adenosine triphosphate-dependent taurocholate transport in canalicular membrane vesicles, was induced by 90% (P < 0.05). AdhAQP1 administration in noncholestatic rats induced no significant changes in either biliary BS output or BSEP activity. Canalicular BSEP, mostly present in raft (high cholesterol) microdomains in control rats, was largely found in nonraft (low cholesterol) microdomains in cholestasis. Considering that BSEP activity directly depends on canalicular membrane cholesterol content, decreased BSEP presence in rafts may contribute to BSEP activity decline in 17α-ethinylestradiol cholestasis. In AdhAQP1-transduced cholestatic rats, BSEP showed a canalicular microdomain distribution similar to that of control rats, which provides an explanation for the improved BSEP activity.
CONCLUSION: Hepatocyte canalicular expression of hAQP1 through adenoviral gene transfer promotes biliary BS output by modulating BSEP activity in estrogen-induced cholestasis, a novel finding that might help us to better understand and treat cholestatic disorders. (Hepatology 2016;64:535-548).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26999313     DOI: 10.1002/hep.28564

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

Review 1.  Aquaporin-Targeted Therapeutics: State-of-the-Field.

Authors:  Lukmanee Tradtrantip; Bjung-Ju Jin; Xiaoming Yao; Marc O Anderson; Alan S Verkman
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

2.  Integrated Lipidomics and Metabolomics Study of Four Chemically Induced Mouse Models of Acute Intrahepatic Cholestasis.

Authors:  Weiwei Li; Hui Chen; Yihan Qian; Shouchuan Wang; Zichen Luo; Jinjun Shan; Xiaoni Kong; Yueqiu Gao
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

Review 3.  Gene Therapy for Acquired and Genetic Cholestasis.

Authors:  Javier Martínez-García; Angie Molina; Gloria González-Aseguinolaza; Nicholas D Weber; Cristian Smerdou
Journal:  Biomedicines       Date:  2022-05-26

4.  Aquaporin gene therapy for disorders of cholestasis?

Authors:  Lukmanee Tradtrantip; Alan S Verkman
Journal:  Hepatology       Date:  2016-05-28       Impact factor: 17.425

Review 5.  Hepatocyte and Sertoli Cell Aquaporins, Recent Advances and Research Trends.

Authors:  Raquel L Bernardino; Raul A Marinelli; Anna Maggio; Patrizia Gena; Ilaria Cataldo; Marco G Alves; Maria Svelto; Pedro F Oliveira; Giuseppe Calamita
Journal:  Int J Mol Sci       Date:  2016-07-09       Impact factor: 5.923

6.  Effect of YHHJ on the expression of the hepatocellular bile acid transporters multidrug resistance-associated protein 2 and bile salt export pump in ethinylestradiol-induced cholestasis.

Authors:  Jia Liu; Li-Li Hou; Cui-Ying Zhao
Journal:  Exp Ther Med       Date:  2018-02-26       Impact factor: 2.447

Review 7.  Aquaporins Involvement in Pancreas Physiology and in Pancreatic Diseases.

Authors:  Tatjana Arsenijevic; Jason Perret; Jean-Luc Van Laethem; Christine Delporte
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

Review 8.  Molecular Regulation of Canalicular ABC Transporters.

Authors:  Amel Ben Saad; Alix Bruneau; Elodie Mareux; Martine Lapalus; Jean-Louis Delaunay; Emmanuel Gonzales; Emmanuel Jacquemin; Tounsia Aït-Slimane; Thomas Falguières
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

Review 9.  Aquaglyceroporins: Drug Targets for Metabolic Diseases?

Authors:  Giuseppe Calamita; Jason Perret; Christine Delporte
Journal:  Front Physiol       Date:  2018-07-10       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.